Special Diabetes Program Reauthorization Act of 2025

Key Points

• This bill, introduced by Representative DeGette, would provide $160 million each year from 2026 through 2030 to support Type 1 diabetes research. This adds up to a total of $800 million over five years to help scientists find better treatments and a potential cure.
• The funding supports the Special Diabetes Program, which focuses on a disease that affects millions of Americans. Unlike Type 2 diabetes, Type 1 is an autoimmune condition that cannot be prevented by diet or exercise, making medical research essential for those living with it.
• By extending this program, the government ensures that long-term medical studies and clinical trials can continue without stopping. This steady funding helps develop new tools, like better insulin pumps and continuous glucose monitors, that make daily life easier for patients.
• This is a renewal of an existing program that has been around for decades. If Congress does not pass this or a similar bill, the current funding would eventually stop, which could delay the discovery of new medicines and technologies.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.